doxazosin has been researched along with wb 4101 in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bondinell, WE; Hieble, JP; Ruffolo, RR | 1 |
| Ballard, S; Blagg, J; Fox, D; Kenny, B | 1 |
| Pedretti, A; Testa, B; Villa, L; Vistoli, G | 1 |
| Amantini, C; Carrieri, A; Del Bello, F; Farande, Y; Giannella, M; Leonardi, A; Lucciarini, R; Piergentili, A; Pigini, M; Poggesi, E; Quaglia, W; Rafaiani, G; Santoni, G | 1 |
| Amantini, C; Bonifazi, A; Del Bello, F; Farande, Y; Farfariello, V; Giannella, M; Leonardi, A; Menegon, S; Nabissi, M; Piergentili, A; Pigini, M; Poggesi, E; Quaglia, W; Santoni, G | 1 |
2 review(s) available for doxazosin and wb 4101
| Article | Year |
|---|---|
Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification.
Topics: Animals; Humans; Molecular Biology; Molecular Structure; Radioligand Assay; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta | 1995 |
Pharmacological options in the treatment of benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship | 1997 |
3 other study(ies) available for doxazosin and wb 4101
| Article | Year |
|---|---|
Range and sensitivity as descriptors of molecular property spaces in dynamic QSAR analyses.
Topics: Chemical Phenomena; Chemistry, Physical; Ligands; Models, Molecular; Molecular Conformation; Monte Carlo Method; Quantitative Structure-Activity Relationship; Receptors, Adrenergic, alpha-1; Solvents | 2005 |
Structure-activity relationships in 1,4-benzodioxan-related compounds. 9. From 1,4-benzodioxane to 1,4-dioxane ring as a promising template of novel alpha1D-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents.
Topics: Adrenergic alpha-1 Receptor Antagonists; Benzene; Cell Line, Tumor; Cell Survival; Dioxanes; Ethylamines; Humans; Models, Molecular; Molecular Structure; Receptor, Serotonin, 5-HT1A; Receptors, Adrenergic, alpha-1; Serotonin Receptor Agonists; Structure-Activity Relationship | 2008 |
Structure-activity relationships in 1,4-benzodioxan-related compounds. 11. (1) reversed enantioselectivity of 1,4-dioxane derivatives in α1-adrenergic and 5-HT1A receptor binding sites recognition.
Topics: Binding Sites; Cell Line; Dioxanes; Humans; Magnetic Resonance Spectroscopy; Receptor, Serotonin, 5-HT1A; Receptors, Adrenergic, alpha-1; Receptors, Serotonin, 5-HT1; Stereoisomerism; Structure-Activity Relationship | 2013 |